Literature DB >> 21840293

Membrane-bound serine protease inhibitor HAI-1 is required for maintenance of intestinal epithelial integrity.

Makiko Kawaguchi1, Naoki Takeda, Shinri Hoshiko, Kenji Yorita, Takashi Baba, Akira Sawaguchi, Yuriko Nezu, Tsutomu Yoshikawa, Tsuyoshi Fukushima, Hiroaki Kataoka.   

Abstract

Hepatocyte growth factor activator inhibitor type 1 (HAI-1), encoded by the serine protease inhibitor Kunitz type 1 (SPINT1) gene, is a membrane-bound serine protease inhibitor expressed in epithelial tissues. Mutant mouse models revealed that HAI-1/SPINT1 is essential for placental labyrinth formation and is critically involved in regulating epidermal keratinization through interaction with its cognate cell surface protease, matriptase. HAI-1/SPINT1 is abundantly expressed in both human and mouse intestinal epithelium; therefore, we analyzed its role in intestinal function using mice with intestinal epithelial cell-specific deletion of Spint1 generated by interbreeding mice carrying Spint1(LoxP) homozygous alleles with transgenic mice carrying the Cre recombinase gene controlled by the intestine-specific Villin promoter. Although the resulting mice had normal development and appearance, crypts in the proximal aspect of the colon, including the cecum, exhibited histologic abnormalities and increased apoptosis and epithelial cell turnover accompanied by increased intestinal permeability. Distended endoplasmic reticula were observed ultrastructurally in some crypt epithelial cells, indicative of endoplasmic reticular stress. To study the role of HAI-1/SPINT1 in mucosal injury, we induced colitis by adding dextran sodium sulfate to the drinking water. After dextran sodium sulfate treatment, intestine-specific HAI-1/SPINT1-deficient mice had more severe symptoms and a significantly lower survival rate relative to control mice. These results suggest that HAI-1/SPINT1 plays an important role in maintaining colonic epithelium integrity.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21840293      PMCID: PMC3181355          DOI: 10.1016/j.ajpath.2011.06.038

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  40 in total

1.  The activation of matriptase requires its noncatalytic domains, serine protease domain, and its cognate inhibitor.

Authors:  Michael D Oberst; Cicely A Williams; Robert B Dickson; Michael D Johnson; Chen-Yong Lin
Journal:  J Biol Chem       Date:  2003-05-08       Impact factor: 5.157

2.  TMPRSS13, a type II transmembrane serine protease, is inhibited by hepatocyte growth factor activator inhibitor type 1 and activates pro-hepatocyte growth factor.

Authors:  Tomio Hashimoto; Minoru Kato; Takeshi Shimomura; Naomi Kitamura
Journal:  FEBS J       Date:  2010-10-26       Impact factor: 5.542

3.  Requirement of the activity of hepatocyte growth factor activator inhibitor type 1 for the extracellular appearance of a transmembrane serine protease matriptase in monkey kidney COS-1 cells.

Authors:  Yuka Miyake; Satoshi Tsuzuki; Makoto Yasumoto; Tohru Fushiki; Kuniyo Inouye
Journal:  Cytotechnology       Date:  2009-08-05       Impact factor: 2.058

4.  Localization of hepatocyte growth factor activator inhibitor type 1 in Langhans' cells of human placenta.

Authors:  H Kataoka; J Y Meng; H Itoh; R Hamasuna; T Shimomura; T Suganuma; M Koono
Journal:  Histochem Cell Biol       Date:  2000-12       Impact factor: 4.304

5.  Matriptase inhibition by hepatocyte growth factor activator inhibitor-1 is essential for placental development.

Authors:  R Szabo; A Molinolo; K List; T H Bugge
Journal:  Oncogene       Date:  2006-09-18       Impact factor: 9.867

6.  Conserved expression of hepatocyte growth factor activator inhibitor type-2/placental bikunin in human colorectal carcinomas.

Authors:  H Kataoka; H Itoh; H Uchino; R Hamasuna; N Kitamura; K Nabeshima; M Koono
Journal:  Cancer Lett       Date:  2000-02-01       Impact factor: 8.679

7.  Upregulation of HGF activator inhibitor type 1 but not type 2 along with regeneration of intestinal mucosa.

Authors:  H Itoh; H Kataoka; M Tomita; R Hamasuna; Y Nawa; N Kitamura; M Koono
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2000-04       Impact factor: 4.052

8.  Gene-centric association mapping of chromosome 3p implicates MST1 in IBD pathogenesis.

Authors:  P Goyette; C Lefebvre; A Ng; S R Brant; J H Cho; R H Duerr; M S Silverberg; K D Taylor; A Latiano; G Aumais; C Deslandres; G Jobin; V Annese; M J Daly; R J Xavier; J D Rioux
Journal:  Mucosal Immunol       Date:  2008-01-16       Impact factor: 7.313

9.  Hepatocyte growth factor activator inhibitor type 1 regulates epithelial to mesenchymal transition through membrane-bound serine proteinases.

Authors:  Haixia Cheng; Tsuyoshi Fukushima; Nobuyasu Takahashi; Hiroyuki Tanaka; Hiroaki Kataoka
Journal:  Cancer Res       Date:  2009-02-17       Impact factor: 12.701

10.  Defect of hepatocyte growth factor activator inhibitor type 1/serine protease inhibitor, Kunitz type 1 (Hai-1/Spint1) leads to ichthyosis-like condition and abnormal hair development in mice.

Authors:  Koki Nagaike; Makiko Kawaguchi; Naoki Takeda; Tsuyoshi Fukushima; Akira Sawaguchi; Kazuyo Kohama; Mitsuru Setoyama; Hiroaki Kataoka
Journal:  Am J Pathol       Date:  2008-10-02       Impact factor: 4.307

View more
  21 in total

1.  Identification of pharmacodynamic biomarkers and common molecular mechanisms of response to genotoxic agents in cancer cell lines.

Authors:  Dong-Joon Min; Yingdong Zhao; Anne Monks; Alida Palmisano; Curtis Hose; Beverly A Teicher; James H Doroshow; Richard M Simon
Journal:  Cancer Chemother Pharmacol       Date:  2019-07-31       Impact factor: 3.333

2.  Hepatocyte growth factor activator inhibitor type 1 maintains the assembly of keratin into desmosomes in keratinocytes by regulating protease-activated receptor 2-dependent p38 signaling.

Authors:  Makiko Kawaguchi; Ai Kanemaru; Akira Sawaguchi; Koji Yamamoto; Takashi Baba; Chen-Yong Lin; Michael D Johnson; Tsuyoshi Fukushima; Hiroaki Kataoka
Journal:  Am J Pathol       Date:  2015-04-01       Impact factor: 4.307

3.  The crystal structure of a multidomain protease inhibitor (HAI-1) reveals the mechanism of its auto-inhibition.

Authors:  Min Liu; Cai Yuan; Jan K Jensen; Baoyu Zhao; Yunbin Jiang; Longguang Jiang; Mingdong Huang
Journal:  J Biol Chem       Date:  2017-03-27       Impact factor: 5.157

4.  Design and Synthesis of Nonpeptide Inhibitors of Hepatocyte Growth Factor Activation.

Authors:  Phanindra K M Venukadasula; Benjamin Y Owusu; Namita Bansal; Larry J Ross; Judith V Hobrath; Donghui Bao; Jackie W Truss; Murray Stackhouse; Troy E Messick; Lidija Klampfer; Robert A Galemmo
Journal:  ACS Med Chem Lett       Date:  2015-12-22       Impact factor: 4.345

5.  Proteolytic cleavage of Podocin by Matriptase exacerbates podocyte injury.

Authors:  Shota Ozawa; Masaya Matsubayashi; Hitoki Nanaura; Motoko Yanagita; Kiyoshi Mori; Katsuhiko Asanuma; Nobuyuki Kajiwara; Kazuyuki Hayashi; Hiroshi Ohashi; Masato Kasahara; Hideki Yokoi; Hiroaki Kataoka; Eiichiro Mori; Takahiko Nakagawa
Journal:  J Biol Chem       Date:  2020-09-09       Impact factor: 5.157

6.  Matriptase protects against experimental colitis and promotes intestinal barrier recovery.

Authors:  Sarah Netzel-Arnett; Marguerite S Buzza; Terez Shea-Donohue; Antoine Désilets; Richard Leduc; Alessio Fasano; Thomas H Bugge; Toni M Antalis
Journal:  Inflamm Bowel Dis       Date:  2011-11-13       Impact factor: 5.325

7.  Regulation of pericellular proteolysis by hepatocyte growth factor activator inhibitor type 1 (HAI-1) in trophoblast cells.

Authors:  Kazuyo Kohama; Makiko Kawaguchi; Tsuyoshi Fukushima; Chen-Yong Lin; Hiroaki Kataoka
Journal:  Hum Cell       Date:  2012-12-18       Impact factor: 4.174

8.  The protease inhibitor HAI-2, but not HAI-1, regulates matriptase activation and shedding through prostasin.

Authors:  Stine Friis; Katiuchia Uzzun Sales; Jeffrey Martin Schafer; Lotte K Vogel; Hiroaki Kataoka; Thomas H Bugge
Journal:  J Biol Chem       Date:  2014-06-24       Impact factor: 5.157

9.  A Grhl2-dependent gene network controls trophoblast branching morphogenesis.

Authors:  Katharina Walentin; Christian Hinze; Max Werth; Nadine Haase; Saaket Varma; Robert Morell; Annekatrin Aue; Elisabeth Pötschke; David Warburton; Andong Qiu; Jonathan Barasch; Bettina Purfürst; Christoph Dieterich; Elena Popova; Michael Bader; Ralf Dechend; Anne Cathrine Staff; Zeliha Yesim Yurtdas; Ergin Kilic; Kai M Schmidt-Ott
Journal:  Development       Date:  2015-03-15       Impact factor: 6.868

10.  Crystal Structure of a Two-domain Fragment of Hepatocyte Growth Factor Activator Inhibitor-1: FUNCTIONAL INTERACTIONS BETWEEN THE KUNITZ-TYPE INHIBITOR DOMAIN-1 AND THE NEIGHBORING POLYCYSTIC KIDNEY DISEASE-LIKE DOMAIN.

Authors:  Zebin Hong; Laura De Meulemeester; Annemarie Jacobi; Jan Skov Pedersen; J Preben Morth; Peter A Andreasen; Jan K Jensen
Journal:  J Biol Chem       Date:  2016-05-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.